Formosa Pharmaceuticals Announces Exclusive Licensing Agreement with Tabuk Pharmaceuticals, for the Commercialization of Clobetasol Propionate Ophthalmic Suspension, a Novel Medicine for the Treatment of Inflammation and Pain Following Ocular Surgery
Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced today an exclusive license agreementwith Formosa Pharma
Tabuk Pharmaceuticals and Globalpharma Sign an Agreement to Locally manufacture Key Pharmaceutical products in UAE.
Globalpharma and Tabuk Pharmaceuticals, leaders in the pharmaceutical industry in the Middle East and North Africa, announced the signing of a cooperation agreement aimed at enabling local manufacturing of several prod
Tabuk Pharmaceuticals Partners with Bio-Thera Solutions forRights to Manufacture and Commercialize BAT2206,a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
Manufacturing Company (a fully-owned subsidiary of Astra Industrial Group), a leading pharmaceutical company in the Middle East and North Africa (MENA) region, today announced the signing of a license, manufacturing, s
TABUK AND HK INNO.N PARTNER TO BRING K-CAB® (TEGOPRAZAN) AN INNOVATIVE MEDICINE TO THE MENA REGION.
Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced today an exclusive license agreement with HK inno.N, a lead